These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33648758)

  • 1. Differences in tumour heterogeneity based on dynamic contrast-enhanced MRI between tumour and peritumoural stroma for predicting Ki-67 status of invasive ductal carcinoma.
    He X; Zhou J; Ye S; Cheng Q; Miao H; Xu N; Li J; Pan Z; Cheng J; Wang M
    Clin Radiol; 2021 Jun; 76(6):470.e13-470.e22. PubMed ID: 33648758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.
    Fan M; Cheng H; Zhang P; Gao X; Zhang J; Shao G; Li L
    J Magn Reson Imaging; 2018 Jul; 48(1):237-247. PubMed ID: 29219225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ.
    Yoon GY; Choi WJ; Cha JH; Shin HJ; Chae EY; Kim HH
    BMC Med Imaging; 2020 Aug; 20(1):95. PubMed ID: 32787871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study.
    Holli-Helenius K; Salminen A; Rinta-Kiikka I; Koskivuo I; Brück N; Boström P; Parkkola R
    BMC Med Imaging; 2017 Dec; 17(1):69. PubMed ID: 29284425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of dynamic contrast-enhanced magnetic resonance imaging and T2-weighted imaging radiomic features by a canonical correlation analysis-based feature fusion method to predict histological grade in ductal breast carcinoma.
    Fan M; Liu Z; Xie S; Xu M; Wang S; Gao X; Li L
    Phys Med Biol; 2019 Oct; 64(21):215001. PubMed ID: 31470420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-to-enhancement at ultrafast breast DCE-MRI: potential imaging biomarker of tumour aggressiveness.
    Shin SU; Cho N; Kim SY; Lee SH; Chang JM; Moon WK
    Eur Radiol; 2020 Jul; 30(7):4058-4068. PubMed ID: 32144456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer.
    Nagasaka K; Satake H; Ishigaki S; Kawai H; Naganawa S
    Breast Cancer; 2019 Jan; 26(1):113-124. PubMed ID: 30069785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
    Shin JK; Kim JY
    J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomic Machine Learning in Invasive Ductal Breast Cancer: Prediction of Ki-67 Expression Level Based on Radiomics of DCE-MRI.
    Yang H; Wang W; Cheng Z; Zheng T; Cheng C; Cheng M; Wang Z
    Technol Cancer Res Treat; 2024; 23():15330338241288751. PubMed ID: 39431304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of quantitative perfusion parameters on dynamic contrast-enhanced MRI in mammographically occult breast cancer.
    Ryu JK; Rhee SJ; Song JY; Cho SH; Jahng GH
    J Appl Clin Med Phys; 2016 Sep; 17(5):377-390. PubMed ID: 27685105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?
    Jiang L; Zhou Y; Wang Z; Lu X; Chen M; Zhou C
    Eur J Radiol; 2013 Sep; 82(9):1404-9. PubMed ID: 23540946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive ductal breast cancer: preoperative predict Ki-67 index based on radiomics of ADC maps.
    Zhang Y; Zhu Y; Zhang K; Liu Y; Cui J; Tao J; Wang Y; Wang S
    Radiol Med; 2020 Feb; 125(2):109-116. PubMed ID: 31696388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of synthetic MRI in predicting the Ki-67 status of oestrogen receptor-positive breast cancer: a feasibility study.
    Matsuda M; Kido T; Tsuda T; Okada K; Shiraishi Y; Suekuni H; Kamei Y; Kitazawa R; Mochizuki T
    Clin Radiol; 2020 May; 75(5):398.e1-398.e8. PubMed ID: 32019671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association among T2 signal intensity, necrosis, ADC and Ki-67 in estrogen receptor-positive and HER2-negative invasive ductal carcinoma.
    Kim SY; Kim EK; Moon HJ; Yoon JH; Koo JS; Kim SG; Kim MJ
    Magn Reson Imaging; 2018 Dec; 54():176-182. PubMed ID: 30172938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of apparent diffusion coefficient as an imaging biomarker for assessing the proliferative potential of invasive ductal breast cancer.
    Zhuang Z; Zhang Q; Zhang D; Cheng F; Suo S; Geng X; Hua J; Xu J
    Clin Radiol; 2018 May; 73(5):473-478. PubMed ID: 29273228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
    Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
    J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
    Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
    Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of magnetic resonance imaging radiomics features in predicting histologic grade of invasive ductal carcinoma of the breast.
    Yang XL; Ni DH; Yu Y; Zhao JC; Lin R; Xiu C; Chang ZX
    Technol Health Care; 2024; 32(3):1609-1618. PubMed ID: 38393931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of Quantitative MRI Using 3D-QALAS for Discriminating Immunohistochemical Status in Invasive Ductal Carcinoma of the Breast.
    Amano M; Fujita S; Takei N; Sano K; Wada A; Sato K; Kikuta J; Kuwatsuru Y; Tachibana R; Sekine T; Horimoto Y; Aoki S
    J Magn Reson Imaging; 2023 Dec; 58(6):1752-1759. PubMed ID: 36951614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
    Chang RF; Chen HH; Chang YC; Huang CS; Chen JH; Lo CM
    Magn Reson Imaging; 2016 Jul; 34(6):809-819. PubMed ID: 26968141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.